Bile Acids as Hormones: The FXR-FGF15/19 Pathway

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Digestive Diseases

• Publication date

  2015-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000371670PMID 26045265PMCID PMC4465534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A nontumorigenic variant of FGF19 treats cholestatic liver diseases

  2014cited by this paper
• Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.

  2014cited by this paper
• Pleiotropic roles of bile acids in metabolism.

  2013cited by this paper
• Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats.

  2013cited by this paper
• Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism

  2013cited by this paper
• FXR signaling in the enterohepatic system.

  2013cited by this paper
• FGF19 action in the brain induces insulin-independent glucose lowering.

  2013cited by this paper
• Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR

  2012cited by this paper
• Nuclear Receptors HNF4α and LRH-1 Cooperate in Regulating Cyp7a1 in Vivo*

  2012cited by this paper
• FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway.

  2011cited by this paper
• Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.

  2011cited by this paper
• FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis

  2011cited by this paper
• Bile acid transporters

  2009cited by this paper
• FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action*

  2009cited by this paper
• A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.

  2009cited by this paper
• Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis

  2007cited by this paper
• Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine Published, JLR Papers in Press, August 24, 2007.

  2007cited by this paper
• Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man

  2006cited by this paper
• The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice*

  2006cited by this paper
• Identification of a hormonal basis for gallbladder filling

  2006cited by this paper
• Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.

  2006cited by this paper
• Farnesoid X receptor is essential for normal glucose homeostasis.

  2006cited by this paper
• Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.

  2006cited by this paper
• Coordinated Recruitment of Histone Methyltransferase G9a and Other Chromatin-Modifying Enzymes in SHP-Mediated Regulation of Hepatic Bile Acid Metabolism

  2006cited by this paper
• Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

  2005cited by this paper
• Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho.

  2005cited by this paper
• Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

  2004cited by this paper
• Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

  2004cited by this paper
• Role of an mSin3A-Swi/Snf Chromatin Remodeling Complex in the Feedback Repression of Bile Acid Biosynthesis by SHP

  2004cited by this paper
• A G Protein-coupled Receptor Responsive to Bile Acids*

  2003cited by this paper
• Evolutionary conservation of CCND1-ORAOV1-FGF19-FGF4 locus from zebrafish to human.

  2003cited by this paper
• Enterohepatic Circulation of Bile Salts in Farnesoid X Receptor-deficient Mice

  2003cited by this paper
• Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.

  2003cited by this paper
• Redundant pathways for negative feedback regulation of bile acid production.

  2002cited by this paper
• A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.

  2002cited by this paper
• Identification of membrane-type receptor for bile acids (M-BAR).

  2002cited by this paper
• Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.

  2002cited by this paper
• Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.

  2002cited by this paper
• The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors.

  2001cited by this paper
• Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

  2000cited by this paper
• Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4*

  2000cited by this paper
• Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor*

  2000cited by this paper
• Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

  2000cited by this paper
• A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

  2000cited by this paper
• Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain.

  1999cited by this paper
• Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.

  1999cited by this paper
• Bile acids: natural ligands for an orphan nuclear receptor.

  1999cited by this paper
• Identification of a nuclear receptor for bile acids.

  1999cited by this paper
• A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1.

  1997cited by this paper
• Bile acid transporters

  1995cited by this paper
• Identification of a nuclear receptor that is activated by farnesol metabolites.

  1995cited by this paper
• Identification and characterization of a putative bile acid-responsive element in cholesterol 7 alpha-hydroxylase gene promoter.

  1994cited by this paper

• Pleiotropic immunoregulation by bile acids in pathophysiology.

  2026cites this paper
• The gut–heart axis in coronary artery disease: a scoping and narrative review of sex-based microbial and metabolic disparities

  2026cites this paper
• Limonin attenuates hyperlipidemia by regulating the gut microbiota-bile acid-farnesoid X receptor axis.

  2026cites this paper
• Personalized Nutrition Through the Gut Microbiome in Metabolic Syndrome and Related Comorbidities

  2026cites this paper
• A Review on Farnesoid X Receptor (FXR) Modulators Focusing on Benzimidazole Scaffold

  2026cites this paper
• Ergosterol and β-sitosterol exert cholesterol-lowering effects by enhancing gut microbiota-mediated cholesterol sulfonation and total bile acid excretion in mice.

  2026cites this paper
• Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities.

  2026cites this paper
• Polysaccharide from Walnut Green Husk alleviates ochratoxin a-induced anorexia in chicks via m6A-mediated FXR regulation of orexigenic genes

  2026cites this paper
• Bile acid signaling, metabolism, and aging

  2026cites this paper
• Fermented Foods and the Gut–Liver Axis: Modulation of MASLD Through Gut Microbiota

  2026cites this paper
• Inflammation in MASLD progression and cancer

  2025cites this paper
• GPR146 regulates CYP7A1 transcription in cells and in vivo of mice.

  2025cites this paper
• New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024

  2025cites this paper
• Farnesoid X Receptor Regulated Sepsis‐Induced Abnormal Bile Acid Metabolism via the Fibroblast Growth Factor 15/Fibroblast Growth Factor Receptor 4 Pathway

  2025cites this paper
• High plasma fibroblast growth factor 19 is associated with improved prognosis in patients with acute ischemic stroke.

  2025cites this paper
• FXR overexpression alleviates cholestasis via NLRC4 inflammasome suppression and bile acid homeostasis regulation.

  2025cites this paper
• Adverse events associated with obeticholic acid: a real-world, pharmacovigilance study.

  2025cites this paper
• Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges

  2025cites this paper
• Microbiome−mediated crosstalk between T2DM and MASLD: a translational review focused on function

  2025cites this paper
• Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review

  2025cites this paper
• Krüppel-like Factors in the Gastrointestinal Tract

  2025cites this paper
• Liver Metabolism at the Crossroads: The Reciprocal Control of Nutrient-Sensing Nuclear Receptors and Autophagy

  2025cites this paper
• Hidden in the Fat: Unpacking the Metabolic Tango Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Syndrome

  2025cites this paper
• Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead

  2025cites this paper
• Farnesoid X receptor-driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review)

  2025cites this paper
• Modulation of Bile Acids and Farnesoid X Receptor by Dietary Polysaccharides: Critical Roles in Health and Disease

  2025cites this paper
• Evaluation of FXR Activity in Pollutants Identified in Sewage Sludge and Subsequent in Vitro and in Vivo Characterization of Metabolic Effects of Triphenyl Phosphate

  2025cites this paper
• Role of protein regulators of cholesterol homeostasis in immune modulation and cancer pathophysiology.

  2025cites this paper
• The role of gut microbiota on skeletal muscle strength in LDLR knockdown aging mice

  2025cites this paper
• Gut Microbiota Composition Correlates to Trunk Fat Percentage in Male Cynomolgus Macaque Monkeys

  2025cites this paper
• GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications

  2025cites this paper
• Nherf family PDZ scaffold protein 2 (Nherf2) is a major determinant of bile acid pool dynamics and contributes to regulation of Western diet-induced obesity.

  2025cites this paper
• BILE ACIDS IN LIVER AND GASTROINTESTINAL CANCER.

  2025cites this paper
• FXR-targeted drug discovery: Recent advances and therapeutic perspectives.

  2025cites this paper
• Primary biliary cholangitis. Treatment options in 2025. A narrative review

  2025influential citation
• Prevention of Cholestatic Liver Disease Through BCL6-FXR Enterohepatic Crosstalk

  2025cites this paper
• Pathology and Therapeutic Significance of Fibroblast Growth Factors.

  2025cites this paper
• The KLB rs12152703 variant confers protection against hepatic inflammation in MASLD patients by boosting Klotho-beta expression

  2025cites this paper
• Pediatric metabolic dysfunction–associated steatotic liver disease and the gut microbiome: from research landscape to targeted modulation

  2025cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention

  2025cites this paper
• Crosstalk between bile acids and gut microbiota: a potential target for precancerous lesions of gastric cancer

  2025cites this paper
• Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets.

  2025cites this paper
• FGF2 Mediated USP42‐PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration

  2025cites this paper
• The Microbial Bile Acid Metabolite 3-oxo-LCA Inhibits Colorectal Cancer Progression.

  2025cites this paper
• Cholecystectomy effect on the digestive system

  2025cites this paper
• FXR crosstalk with other nuclear receptors

  2025cites this paper
• Interaction Between Gut-Heart Axis in Sepsis-Induced Cardiomyopathy.

  2025cites this paper
• Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization

  2024cites this paper
• Sodium sulphate ameliorates hypercholesterolemia via the upregulation of Cyp7a1 in hepatocytes and alleviates hepatic insulin resistance via the downregulation of Trib3 in mice with high cholesterol diets

  2024cites this paper
• Exploring the metabolic patterns and response mechanisms of bile acids during fasting: A study with poultry as an example

  2024cites this paper
• Perfluoropolyether-Based Gut-Liver-on-a-Chip for the Evaluation of First-Pass Metabolism and Oral Bioavailability of Drugs.

  2024cites this paper
• IBAT inhibitors in pediatric cholestatic liver diseases: Transformation on the horizon?

  2024cites this paper
• Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions

  2024cites this paper
• Comparison of fibroblast growth factor 19 concentrations between dogs with and without gallbladder mucoceles

  2024cites this paper
• Gut dysbiosis impairs intestinal renewal and lipid absorption in Scarb2 deficiency-associated neurodegeneration

  2024cites this paper
• Protective Mechanism of Eurotium amstelodami from Fuzhuan Brick Tea against Colitis and Gut-Derived Liver Injury Induced by Dextran Sulfate Sodium in C57BL/6 Mice

  2024cites this paper
• New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study.

  2024cites this paper
• Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway.

  2024cites this paper
• Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study

  2024cites this paper
• New advances in drug development for metabolic dysfunction-associated diseases and alcohol-associated liver disease

  2024cites this paper
• Overexpression of TNFα in TNF∆ARE+/− mice increases hepatic periportal inflammation and alters bile acid signaling in mice

  2024cites this paper
• Determination of Bile Acids in Canine Biological Samples: Diagnostic Significance

  2024cites this paper
• The bile-gut axis and metabolic consequences of cholecystectomy.

  2024cites this paper
• Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance

  2024cites this paper
• Role of the microbiota-gut-heart axis between bile acids and cardiovascular disease.

  2024cites this paper
• Diagnosis, Management, and Prognosis of Cystic Fibrosis-Related Liver Disease in Children

  2024cites this paper
• Novel preclinical developments of the primary sclerosing cholangitis treatment landscape

  2024cites this paper
• Review of the Relationships Between Human Gut Microbiome, Diet, and Obesity

  2024cites this paper
• Biological functions and pharmacological behaviors of bile acids in metabolic diseases

  2024cites this paper
• Alleviation of Alcoholic Liver Injury through Composite Postbiotics Regulation of Intestinal Flora and Promotion of Bile Acid Metabolism

  2024cites this paper
• Lactobacillus johnsonii CCFM1376 improves hypercholesterolemia in mice by regulating the composition of bile acids

  2024cites this paper
• The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis

  2024cites this paper
• Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights.

  2024cites this paper
• Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance

  2024cites this paper
• Research Progress on the Effects of FXR on the Development of Colorectal Cancer

  2024cites this paper
• A Narrative Review: Immunometabolic Interactions of Host–Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers

  2024cites this paper
• The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease

  2024cites this paper
• Feeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis

  2024cites this paper
• Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion

  2024cites this paper
• Simiao Wan attenuates high-fat diet-induced hyperlipidemia in mice by modulating the gut microbiota-bile acid axis.

  2024cites this paper
• α-Linolenic acid from Mori Folltfm found as Choloylglycine hydrolase inhibitor by the developed fluorescent probe to alleviate type 2 diabetes

  2024cites this paper
• RISE IN PLASMA BILE ACIDS FOLLOWING HYPOABSORPTIVE BARIATRIC SURGERIES PREDICT BENEFICIAL METABOLIC AND HOMEOSTATIC OUTCOMES IN MALE RATS.

  2024cites this paper
• Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid.

  2024cites this paper
• Apple Polyphenol Extracts Attenuated Depressive-Like Behaviors of High-Sucrose Diet Feeding Mice by Farnesoid X Receptor-Mediated Modulation of Bile Acid Circulation within the Liver-Gut-Brain Axis.

  2024cites this paper
• Bifidobacterium animalis subsp. lactis F1-7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR.

  2024cites this paper
• Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids

  2024cites this paper
• Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress.

  2024cites this paper
• Development of Cilofexor, an Intestinally-Biased Farnesoid X Receptor Agonist, for the Treatment of Fatty Liver Disease

  2024cites this paper
• Activation of TGR5 Increases Urine Concentration by Inducing AQP2 and AQP3 Expression in Renal Medullary Collecting Ducts

  2024cites this paper
• Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: correlations with glycemic control, liver phenotypes and metabolic biomarkers

  2024cites this paper
• Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice

  2024cites this paper
• Targeting Gut Microbiota for the Treatment of Primary Biliary Cholangitis: From Bench to Bedside

  2023cites this paper
• Smooth muscle cells, interstitial cells and neurons in the gallbladder (GB): Functional syncytium of electrical rhythmicity and GB motility (Review)

  2023cites this paper
• The role of bile acids in regulating glucose and lipid metabolism.

  2023cites this paper
• Ganoderma lucidum polysaccharides improve lipid metabolism against high-fat diet-induced dyslipidemia.

  2023cites this paper
• First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors

  2023cites this paper
• Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease.

  2023cites this paper
• Management of metabolic-associated fatty liver disease: The diabetology perspective

  2023cites this paper
• Ingestion of whey protein and β-conglycinin exerts opposite effects on intestinal FGF15 and serotonin secretion in mice

  2023cites this paper
• Bile acids as modulators of gut microbiota composition and function

  2023influential citation